Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Other Non-Current Assets (2017 - 2024)

Grifols' (GIFLF) quarterly Other Non-Current Assets came in at $146.4 million in Q4 2024, little changed on a YoY basis from $145.9 million in Q1 2024, and little changed quarter-over-quarter from $145.9 million in Q4 2023.

Analysis

Grifols (GIFLF) Other Non-Current Assets (2017 - 2024) Analysis & Trends

Grifols (GIFLF) has reported Other Non-Current Assets for 8 consecutive years, with $146.4 million the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Assets changed 0.32% year-over-year to $146.4 million; the trailing twelve-month figure through Dec 2024 stood at $146.4 million (changed 0.32% YoY), and the FY2024 full-year result was $146.4 million, changed 0.32% from the prior year.
  • Other Non-Current Assets steadied at $146.4 million in Q4 2024 per GIFLF's latest filing, from $145.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.3 billion in Q4 2021 and bottomed at $2.8 million in Q4 2020.
  • Historically, Other Non-Current Assets has averaged $431.4 million across 5 years, with a median of $145.9 million in 2023.
  • The sharpest annual moves came in 2020 and 2021: Other Non-Current Assets tumbled 97.94% in 2020, then soared 82169.78% in 2021.
  • Over 5 years, Other Non-Current Assets stood at $2.8 million in 2020, then jumped by 82169.78% to $2.3 billion in 2021, then plunged by 94.5% to $126.7 million in 2022, then climbed by 15.17% to $145.9 million in 2023, then climbed by 0.32% to $146.4 million in 2024.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $146.4 million, $145.9 million, and $126.7 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 124.00 Mn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 65.13 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 29.59 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 146.40 Mn
Dec 31, 2023 145.93 Mn
Dec 31, 2022 126.71 Mn
Dec 31, 2021 2.31 Bn
Dec 31, 2020 2.80 Mn
Sep 30, 2020 147.64 Mn
Mar 31, 2020 145.22 Mn
Dec 31, 2019 136.17 Mn
Sep 30, 2019 133.28 Mn
Mar 31, 2019 137.44 Mn
Dec 31, 2018 128.45 Mn
Sep 30, 2018 78.26 Mn
Mar 31, 2018 75.04 Mn
Dec 31, 2017 77.90 Mn